Sunekos Cell

to counteract acidosis
 to restore the extracellular matrix

The new era of cellulite treatment
DESIGNED to RECREATE

WHAT’S NEW ABOUT CELLULITE?

In the evolutionary phases of cellulite, clinically called “Panniculopathic Edematous Fibro Sclerosis tissue” (PEFS) the intradermal therapy was mainly addressed to the treatment of edema and microcirculation.

Today, numerous pathophysiological considerations demonstrate the need to intervene also and especially on the extracellular matrix.

The synergy of the mix of HA+AA and an Alkaline Solution determines the physiological induction of the precise mechanisms to improve the structure of the ECM, adjusting micro circulation and reducing fibrosis.

Sunekos Cell acts:

  • Optimization of the ECM protein turnover: neo-collagenesis and not collagenase (HA + AA)
  • Improvement of the micro-circulation
  • Re-equilibrium of the ECM inflammation reducing fibrosis

REBUILDING rather than DESTROYING.

Sunekos Cel Pack

STAGES OF CELLULITE

Indication

STAGES I AND II
OF CELLULITE

ATL needle Technique logo
Stage 1 and 2 ATL Needle Technique



ATL Needle Technique Protocol

Maintenance 1 or 2 sessions after 6 months

Repeat the full cycle every 12 months

Indication

STAGES III AND IV
OF CELLULITE

ATL cannula Technique logo
Stage 3 and 4 ATL Needle Technique



ATL Needle Technique Protocol at stage 3 and 4

Maintenance or 2 sessions after 6 months

Repeat the full cycle every 12 months

CLINICAL EVALUTATION

Preliminary study on 25 healthy subjects with different stages of cellulite, divided into 2 groups, undergoing Sunekos Cell treatment.*

Group A: 11 subjects with stages I and II cellulite

Group B: 14 subjects with stages III and IV cellulite

Clinical, morphometric and ultrasound evaluation at baseline, 1 month and 4 months after the treatment

CIRCUMFERENCES

VISUAL ASPECT GRADE

ULTRASOUND

CONCLUSION

  • Effectiveness of Sunekos Cell.

RESULTS*

  • Clinical evaluation score is reduced in both groups also thanks to the injective technique adapted to the severity of the disease.
  • Maintenance of results after 4 months.

*Preliminary study:
“Injective treatment of the so-called cellulite: a new approach aimed at restructuring extracellular matrix of deeper layers of the skin. Efficacy and safetyof a new specific formula” – Sparavigna A.
The study has been performed with estabilished techniques (2 sessions).

Do you want to become a Sunekos distributor?
Contact us now!